🇺🇸 FDA
Patent

US 11369575

PPARα agonist compositions and methods of use

granted A61KA61K31/216A61K47/02

Quick answer

US patent 11369575 (PPARα agonist compositions and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/216, A61K47/02, A61K47/10, A61K9/0014